Clinical Assessment

in Overview of Vascular Disease

Applied

Type

Modification

Confidence

88%

Created

Mar 27, 2026

Evidence

3 sources

Rationale

The section was updated to include recent 2025/2026 evidence. The ACC 2025 statement provides specific guidance for diabetic PAD assessment (foot exams). The SMART2-HF model (2026) adds a new dimension to cardiac risk assessment beyond MACE, focusing on heart failure in ASCVD patients. The systematic review by Lyons et al. (2026) supports the anatomic component of the PLAN framework. All abbreviations were expanded on first use as per instructions.

Content Changes

History of claudication, rest pain, ulceration, or embolic events is essential. On examination:

* **Arterial:** pulse deficit, bruits, trophic skin changes. In patients with diabetes, a comprehensive foot examination is mandatory to identify neuropathy, deformity, and skin integrity issues [@acc2025].
* **Venous:** varicosities, edema, skin pigmentation, ulceration.
* **Lymphatic:** swelling, non-pitting edema, skin thickening.

For peripheral arterialartery disease (PAD), risk-stratify limb threat with Wound, Ischemia, and foot Infection (WIfI) staging (wound, ischemia, infection) and integrate with patient riskrisk, limb threat, and anatomyanatomic pattern (PLAN) to guide revascularization strategy [@conte2019-gvg]. Angiographic scoring systems within the PLAN framework are increasingly utilized to predict clinical outcomes and technical success [@lyons2026].

### Perioperative Cardiac Risk Assessment

Vascular surgery patients have high rates of coronary artery disease. The Revised Cardiac Risk Index (RCRI) helps stratify perioperative major adverse cardiac events (MACE) risk before non-cardiac surgery [@lee1999]. Vascular procedures (especially aortic and lower extremity) are classified as high-risk surgery, contributing 1 point to the RCRI score. In patients with established atherosclerotic cardiovascular disease (ASCVD), the SMART2-HF model may be used to predict the risk of incident heart failure, further refining the clinical profile of the high-risk vascular patient [@reitsma2026].

:::widget{type="calculator" id="rcri"}
{}
:::